Nick Ross has been appointed by Talentmark, to build and grow the executive interim side of the business in pharmaceuticals, biotechnology and medical devices.

Nick has track-record in advising a range of specialist customers from small biotechs to larger more established businesses and has matched clients with some of the most experienced interim talent in the sector. Typical assignments range from launching a new healthcare project to delivering key work streams and successful financing rounds.

David Nolan, Talentmark Group CEO, commented:

“Executive Interims have become fundamental to how dynamic organisations operate in challenging environments where disruption and convergence are the norm. Nick’s deep insight and expertise of how interim can help organisations through periods of transformation and change will be a great asset. We are very pleased to have him on the team and to welcome him to the team alongside two other key new joiners, Jon Phillips and Andreea-Godfrey Cass.”

SOURCE: Press release